Problems with Using Women's Cancer Screening Rates to Measure Performance
Paul A. Heineken, MD, Cheryl Wenell, RNP, MS, Karla Kerlikowske, MD, and Louise C. Walter, MD
Dr. Heineken is the associate chief of staff of ambulatory care, Ms. Wenell is the coordinator of the Women Veterans Program, Dr. Kerlikowske is the director of the Women's Clinic, and Dr. Walter is a staff physician, all at the San Francisco VA Medical Center, San Francisco, CA. In addition, Dr. Heineken is a clinical professor in the School of Medicine, Ms. Wenell is an associate clinical professor in the School of Nursing, Dr. Kerlikowske is a professor in residence in the departments of medicine and epidemiology and biostatistics in the School of Medicine, and Dr. Walter is an associate professor in the division of geriatrics and the codirector of the Geriatrics Research Program in the School of Medicine, all at the University of California, San Francisco.
When a VA audit determined that the San Francisco VA Medical Center had underperformed with regard to breast and cervical cancer screening, these authors reviewed the medical charts of patients who were counted as screening failures. Their findings point to flaws with the VA’s auditing process and its use of women’s cancer screening rates as performance measures.
Clinical Topics
-
Is early-onset cancer an emerging global epidemic? -
Cost paramount when choosing metastatic breast cancer treatment Publish date: September 30, 2022 -
Genetic tests create treatment opportunities and confusion for breast cancer patients Publish date: September 22, 2022 -
Time to cancer diagnoses in U.S. averages 5 months Publish date: September 15, 2022 -
Single Institution Retrospective Review of Patterns of Care and Disease Presentation in Female Veterans With Breast Cancer During the COVID-19 Pandemic
Digital Edition
-
Publish date: July 5, 2023
-
Publish date: March 30, 2022
-
Publish date: September 22, 2021
-
Publish date: September 3, 2021
-
Publish date: May 20, 2021
Multimedia
-
Data underscore the importance of lifestyle interventions in breast cancer patients Publish date: December 17, 2018 -
Publish date: December 14, 2018
-
Extending Therapy for Breast Cancer Publish date: September 3, 2014
Conference Coverage
-
Particulate pollution increases the risk for breast cancer Publish date: November 9, 2023 -
Dato-DXd trumps chemo in advanced HR+/HER2– breast cancer Publish date: October 25, 2023 -
The sobering facts about alcohol and cancer Publish date: October 25, 2023 -
ICIs improve pCR rates in early ER+/HER2– breast cancer Publish date: October 22, 2023 -
No benefit to adding ICI to chemo in triple-negative breast cancer: study Publish date: October 22, 2023 -
Remote symptom monitoring in advanced cancer improves quality of life Publish date: October 22, 2023 -
Fasting during breast cancer chemo improves quality of life Publish date: October 22, 2023 -
Adjuvant abemaciclib-ET combo shows long-term benefit in high-risk early breast cancer Publish date: October 20, 2023 -
Adopting high-dose radiation vs. conventional after mastectomy could be ‘game changer’ Publish date: October 4, 2023 -
Multiprong strategy makes clinical trials less White Publish date: June 23, 2023
Factors related to breast cancer surgery choices
![](https://qa00.mdedge.com/sites/all/modules/features/medstat_quizz/images/md-iq.jpg)